Fisher Scientific Completes Sale of Atos Medical AB

    Business Editors/Health/Medical Writers

    HAMPTON, N.H.--(BUSINESS WIRE)--April 5, 2005--Fisher Scientific International Inc. (NYSE: FSH) today completed its sale of Atos Medical AB, a manufacturer of ear, nose and throat medical devices with 2004 sales totaling $35 million, to Nordic Capital for $110 million in cash.
    Acquired by Fisher in its 2003 transaction with Perbio Science AB, Sweden-based Atos Medical is a world leader in providing devices designed to rehabilitate the voice and pulmonary functions after laryngectomy for the treatment of cancer. Atos also provides other devices for the treatment of ear and sinus diseases.

    Fisher Scientific: A World Leader in Serving Science

    Fisher Scientific International Inc. (NYSE: FSH) is a leading provider of products and services to the scientific community. Fisher facilitates discovery by supplying researchers and clinicians in labs around the world with the tools they need. We serve pharmaceutical and biotech companies; colleges and universities; medical-research institutions; hospitals; reference, quality-control, process-control and R&D labs in various industries; as well as governments and first responders. From biochemicals, cell-culture media and proprietary RNAi technology to rapid-diagnostic tests, safety products and other consumable supplies, Fisher provides more than 600,000 products and services. This broad offering, combined with Fisher's globally integrated supply chain and unmatched sales and marketing presence, helps make our 350,000 customers more efficient and effective at what they do.
    Founded in 1902, Fisher Scientific is a FORTUNE 500 company and is a component of the S&P 500 Index. Fisher has approximately 17,500 employees worldwide, and our annual revenues are expected to exceed $5.5 billion in 2005. Fisher Scientific is a company committed to high standards and delivering on our promises -- to customers, shareholders and employees alike. Additional information about Fisher is available on the company's Web site at www.fisherscientific.com.

--30--SP/bo*

CONTACT: Fisher Scientific International Inc. Media Contact: Gia L. Oei, 603-929-2489 Gia.Oei@fishersci.com or Investor Contact: Carolyn Miller, 603-929-2381 Carolyn.Miller@fishersci.com

KEYWORD: NEW HAMPSHIRE INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL DEVICES BIOTECHNOLOGY MERGERS/ACQ SOURCE: Fisher Scientific International Inc.

Copyright Business Wire 2005